| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | Sep 30, 2024 | Viridian Therapeutics, Inc.\DE | CEO | Buy | 97.5 | +21,400 | 100.00% | ✗ | $499.3K |
| Sep 16, 2021 | Sep 20, 2021 | Dianthus Therapeutics, Inc. /DE/ | Officer | Sell | 26.3 | -5,736 | -28.68% | ✗ | $38.6K |